Simplify Logo

Full-Time

Automation Scientist

I, II, III

Confirmed live in the last 24 hours

Cellares

Cellares

51-200 employees

Integrated platform for cell therapy manufacturing

Data & Analytics
Hardware
Biotechnology

Compensation Overview

$90k - $210kAnnually

Mid

San Bruno, CA, USA

Category
Bioinformatics
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Master's or Ph.D. in Bioengineering, Biotechnology, Chemistry, Molecular Biology, or a related field
  • 3+ years of relevant experience
  • Experience with assay method development for high-throughput screening
  • Experience with laboratory analytical instruments and automated systems
  • Experience with laboratory information systems (LIMS) and data analysis tools
  • Familiarity with DoE (Design of Experiments) principles and best practices
  • Strong technical writing skills and experience authoring Standard Operating Procedures (SOPs), documentation, and training materials
  • Familiarity with GMP compliance requirements
  • Familiarity with statistical analysis software tools
  • Creative, self-motivated, eager to take on a wide variety of tasks and grow with the evolving technology
  • Self-awareness, integrity, authenticity, and a growth mindset
Responsibilities
  • Collaborate in the design and development of fully automated QC methods
  • Analyze automation workflows to identify bottlenecks and areas for optimization
  • Troubleshoot and resolve technical issues related to automation systems and instrumentation
  • Develop sample and reagent format and storage management strategies
  • Coordinate DoEs (Design of Experiments) to optimize assay method parameters
  • Coordinate the validation and verification testing of automated methods to ensure precision, accuracy, and reproducibility of results
  • Implement quality control measures to maintain the high-quality generation
  • Implement troubleshooting methodologies to identify and resolve complex assay method issues

Cellares offers the Cell Shuttle, an integrated platform for cell therapy manufacturing, utilizing Industry 4.0 technologies to enable true walk-away, end-to-end automation, modular hardware, purpose-built process design software, and scalable manufacturing from preclinical to commercial scale, resulting in reduced process failure rates and up to 70% cost reduction compared to manual processes. The company aims to accelerate access to life-saving cell therapies by deploying Cell Shuttles in Smart Factories globally, partnering with academia, biotechs, and pharma companies to lower manufacturing costs and meet global patient demand.

Company Stage

Series C

Total Funding

$373M

Headquarters

South San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

17%

1 year growth

34%

2 year growth

95%